Evidence map›Paper›PMID 29123802›Full record

ReviewAcute medicine & surgery2016

Lactate, a useful marker for disease mortality and severity but an unreliable marker of tissue hypoxia/hypoperfusion in critically ill patients.

Shigeki Kushimoto, Satoshi Akaishi, Takeaki Sato, Ryosuke Nomura, Motoo Fujita, Daisuke Kudo, Yu Kawazoe, Yoshitaro Yoshida, Noriko Miyagawa

Open access · greenAbstract readReview
In one paragraph

Review in Acute medicine & surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Hour-1 Sepsis Bundle: Updated Evidence.Journal of clinical medicine · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. A different perspective in trauma patients: can pan-immune-inflammation value (PIV) predict mortality?Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2026
    Article
  11. Article
  12. Observational
  13. Observational
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Biomarkers help identify critically injured patients with only moderate risk of severe injuries in trauma team activation.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shigeki KushimotoDivision of Emergency and Critical Care Medicine Tohoku University Graduate School of Medicine Aoba-ku Sendai Miyagi Japan.
Satoshi AkaishiDepartment of Emergency and Critical Care Medicine Tohoku University Hospital Aoba-ku Sendai Miyagi Japan.
Takeaki SatoDepartment of Emergency and Critical Care Medicine Tohoku University Hospital Aoba-ku Sendai Miyagi Japan.
Ryosuke NomuraDepartment of Emergency and Critical Care Medicine Tohoku University Hospital Aoba-ku Sendai Miyagi Japan.
Motoo FujitaDepartment of Emergency and Critical Care Medicine Tohoku University Hospital Aoba-ku Sendai Miyagi Japan.
Daisuke KudoDivision of Emergency and Critical Care Medicine Tohoku University Graduate School of Medicine Aoba-ku Sendai Miyagi Japan.
Yu KawazoeDepartment of Emergency and Critical Care Medicine Tohoku University Hospital Aoba-ku Sendai Miyagi Japan.
Yoshitaro YoshidaDepartment of Emergency and Critical Care Medicine Tohoku University Hospital Aoba-ku Sendai Miyagi Japan.
Noriko MiyagawaDepartment of Emergency and Critical Care Medicine Tohoku University Hospital Aoba-ku Sendai Miyagi Japan.
Tohoku University Hospital · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early aggressive hemodynamic resuscitation using elevated plasma lactate as a marker is an essential component of managing critically ill patients. Therefore, measurement of blood lactate is recommended to stratify patients based on the need for fluid resuscitation and the risks of multiple organ dysfunction syndrome and death. Hyperlactatemia is common among critically ill patients, and lactate levels and their trend may be reliable markers of illness severity and mortality. Although hyperlactatemia has been widely recognized as a marker of tissue hypoxia/hypoperfusion, it can also result from increased or accelerated aerobic glycolysis during the stress response. Additionally, lactate may represent an important energy source for patients in critical condition. Despite its inherent complexity, the current simplified view of hyperlactatemia is that it reflects the presence of global tissue hypoxia/hypoperfusion with anaerobic glycolysis. This review of hyperlactatemia in critically ill patients focuses on its pathophysiological aspects and recent clinical approaches. Hyperlactatemia in critically ill patients must be considered to be related to tissue hypoxia/hypoperfusion. Therefore, appropriate hemodynamic resuscitation is required to correct the pathological condition immediately. However, hyperlactatemia can also result from aerobic glycolysis, unrelated to tissue dysoxia, which is unlikely to respond to increases in systemic oxygen delivery. Because hyperlactatemia may be simultaneously related to, and unrelated to, tissue hypoxia, physicians should recognize that resuscitation to normalize plasma lactate levels could be over-resuscitation and may worsen the physiological status. Lactate is a reliable indicator of sepsis severity and a marker of resuscitation; however, it is an unreliable marker of tissue hypoxia/hypoperfusion.

Indexed as

Beta‐2 adrenergic receptorgluconeogenesishypoperfusionlactateresuscitation

Identifiers

PMID29123802
PMCPMC5667335
OpenAlexW2403408669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.